Overview

Effects of Iloprost on Hypoxic Pulmonary Vasoconstriction and Exercise Capacity at High Altitude

Status:
Unknown status
Trial end date:
2008-10-01
Target enrollment:
Participant gender:
Summary
The objective of this study is to determine if single dose administration of inhaled iloprost will reduce pulmonary artery pressure, reduce hypoxic pulmonary vasoconstriction and improve arterial oxygenation at rest and during exercise at high altitude.
Phase:
Phase 1
Details
Lead Sponsor:
VA Loma Linda Health Care System
Collaborator:
Actelion
Treatments:
Iloprost